Recursion Pharmaceuticals Inc (RXRX)
5.70
-0.05
(-0.87%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.05
(+0.88%)
After-Hours: 20:00
Recursion Pharmaceuticals Cash from Operations (Quarterly): -59.22M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -59.22M |
| June 30, 2024 | -82.22M |
| March 31, 2024 | -102.30M |
| December 31, 2023 | -74.08M |
| September 30, 2023 | -72.92M |
| June 30, 2023 | -67.47M |
| March 31, 2023 | -73.32M |
| December 31, 2022 | -44.75M |
| September 30, 2022 | -54.54M |
| June 30, 2022 | -61.62M |
| Date | Value |
|---|---|
| March 31, 2022 | 77.39M |
| December 31, 2021 | -61.16M |
| September 30, 2021 | -33.05M |
| June 30, 2021 | -33.65M |
| March 31, 2021 | -30.76M |
| December 31, 2020 | 8.573M |
| September 30, 2020 | -19.46M |
| June 30, 2020 | -16.70M |
| March 31, 2020 | -17.82M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-102.30M
Minimum
Mar 2024
77.39M
Maximum
Mar 2022
-43.11M
Average
-54.54M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| Revance Therapeutics Inc | -41.09M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
| iBio Inc | -3.715M |
| Theriva Biologics Inc | -3.913M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.562M |
| Cash from Financing (Quarterly) | 16.46M |
| Free Cash Flow | -335.64M |
| Free Cash Flow Per Share (Quarterly) | -0.2257 |
| Free Cash Flow to Equity (Quarterly) | -61.49M |
| Free Cash Flow to Firm (Quarterly) | -63.79M |
| Free Cash Flow Yield | -23.96% |